Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Date

September 27, 2022

Global Biopharmaceutical Leader to Usher C-Path in Next Phase of Growth and Innovation

Board names Dr. Daniel Jorgensen as Chief Executive Officer TUCSON, Ariz., Sept. 27, 2022 — Critical Path Institute (C-Path) tod

September 22, 2022

View Now: Workshop: Accelerating Medical Product Development in Kidney Transplantation Through a Public-private Partnership

C-Path’s Transplant Therapeutics Consortium (TTC), in collaboration with key opinion leaders from academic institutions, the pha

September 21, 2022

Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports

September 20, 2022

C-Path’s European Nonprofit Appoints Managing Director and New Board Member to Expand Global Efforts

TUCSON, Ariz. and AMSTERDAM, September 20, 2022 — Critical Path Institute’s (C-Path) European nonprofit today announced the ap

September 15, 2022

Rare Disease Workshop Highlights the Importance of Data Sharing in Drug Development

C-Path, NORD and FDA hosted an annual workshop September 13-14 to spotlight the impact of their innovative data and analytics plat

September 14, 2022

C-Path Awarded FDA Grant to Establish Public-Private Partnership to Advance Treatments for Rare Neurodegenerative Diseases

TUCSON, Ariz., Sept. 14, 2022 — Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Pat

September 13, 2022-September 14, 2022

View Now | 2022 RDCA-DAP Workshop, September 13-14

Since its launch in 2019, the Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) has established i

September 8, 2022

C-Path’s Kristen Swingle Named President

Swingle joined C-Path in 2019 and was named interim president in 2021 TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-

September 7, 2022

Evaluating the Use of Backup Solutions for ePRO Systems has been published in Applied Clinical Trials

September 1, 2022

Drug Development for Cystic Kidney Diseases

Inherited cystic diseases include a spectrum of disorders, such as autosomal dominant polycystic kidney disease (ADPKD), autosomal

Previous5051 52...135 Next